SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novavax NVAX
NVAX 7.800+3.9%2:41 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (31)6/10/2009 1:01:55 PM
From: Rock_nj   of 166
 
What, the Swine Flu pandemic or NVAX's price? We ain't seen nothing yet on either front. A Swine Flu pandemic with no resistence in the under 60 population could easily infect 30% or 2 Billion people over the next year or so. NVAX could easily get fast track approval and be selling swine flu vaccines hand over fist by this time next year. NVAX could be a huge runner for 2009.

Check this post on December 31, 2009. NVAX started about $2.80 today and is now about $3.20. Where will it be at the end of the year? I think a lot higher since they have no revenues no and might have Billions in revenues shortly.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext